Between subtypes of breast cancer patient tumors, TNBC/basal tumors showed significantly higher OGT expression than estrogen/progesterone receptor-expressing luminal A/B breast tumors (Fig. 2b). This evidence concerns the gene OGT and breast carcinoma.